HomeCompareNEPT vs ORCC

NEPT vs ORCC: Dividend Comparison 2026

NEPT yields 1000.00% · ORCC yields 9.79%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NEPT wins by $18844438.66M in total portfolio value
10 years
NEPT
NEPT
● Live price
1000.00%
Share price
$0.20
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$18844438.68M
Annual income
$15,746,803,993,532.36
Full NEPT calculator →
ORCC
ORCC
● Live price
9.79%
Share price
$13.48
Annual div
$1.32
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$1.04
Full ORCC calculator →

Portfolio growth — NEPT vs ORCC

📍 NEPT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNEPTORCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NEPT + ORCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NEPT pays
ORCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NEPT
Annual income on $10K today (after 15% tax)
$85,000.00/yr
After 10yr DRIP, annual income (after tax)
$13,384,783,394,502.51/yr
ORCC
Annual income on $10K today (after 15% tax)
$832.34/yr
After 10yr DRIP, annual income (after tax)
$0.88/yr
At 15% tax rate, NEPT beats the other by $13,384,783,394,501.62/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NEPT + ORCC for your $10,000?

NEPT: 50%ORCC: 50%
100% ORCC50/50100% NEPT
Portfolio after 10yr
$9422219.35M
Annual income
$7,873,401,996,766.70/yr
Blended yield
83.56%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

NEPT
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
-5971.0
Piotroski
3/9
ORCC
Analyst Ratings
9
Buy
4
Hold
1
Sell
Consensus: Buy
Price Target
$16.00
+18.7% upside vs current
Range: $16.00 — $16.00
Altman Z
0.5
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NEPT buys
0
ORCC buys
0
No recent congressional trades found for NEPT or ORCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNEPTORCC
Forward yield1000.00%9.79%
Annual dividend / share$2.00$1.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%-50%
Portfolio after 10y$18844438.68M$21.4K
Annual income after 10y$15,746,803,993,532.36$1.04
Total dividends collected$18607754.73M$1.0K
Payment frequencyquarterlyquarterly
SectorStockBDC
Analyst consensusBuyBuy

Year-by-year: NEPT vs ORCC ($10,000, DRIP)

YearNEPT PortfolioNEPT Income/yrORCC PortfolioORCC Income/yrGap
1← crossover$110,700$100,000.00$11,190$489.61+$99.5KNEPT
2$1,153,028$1,034,579.44$12,229$256.01+$1.14MNEPT
3$11,304,737$10,070,996.94$13,216$130.74+$11.29MNEPT
4$104,376,400$92,280,331.11$14,207$66.02+$104.36MNEPT
5$907,965,307$796,282,558.81$15,234$33.17+$907.95MNEPT
6$7,445,190,031$6,473,667,152.78$16,317$16.62+$7445.17MNEPT
7$57,576,798,154$49,610,444,821.11$17,468$8.32+$57576.78MNEPT
8$420,166,535,918$358,559,361,892.40$18,695$4.16+$420166.52MNEPT
9$2,894,985,686,808$2,445,407,493,376.48$20,006$2.08+$2894985.67MNEPT
10$18,844,438,678,417$15,746,803,993,532.36$21,407$1.04+$18844438.66MNEPT

NEPT vs ORCC: Complete Analysis 2026

NEPTStock

Neptune Wellness Solutions Inc. operates as an integrated health and wellness company in Canada, the United States, and internationally. It builds a portfolio of lifestyle brands and consumer packaged goods products under the Biodroga, Forest Remedies, Ocean Remedies, Neptune Wellness, Mood Ring, PanHash, Sprout, Nosh, MaxSimil, and NurturMe brands. The company also offers turnkey product development and supply chain solutions to business customers in various health and wellness verticals, including nutraceuticals, beauty and personal care products, and organic foods and beverages. In addition, it is involved in the extraction, purification, formulation, and manufacturing of health and wellness products. Further, the company offers Maxsimil, an omega-3 fatty acid delivery technology that uses enzymes that mimic the natural human digestive system to predigest omega-3 fatty acids. It has a collaboration agreement with International Flavors & Fragrances Inc. to co-develop hemp-derived CBD products for the mass retail, and health and wellness markets. The company was incorporated in 1998 and is headquartered in Laval, Canada.

Full NEPT Calculator →

ORCCBDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →
📬

Get this NEPT vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NEPT vs SCHDNEPT vs JEPINEPT vs ONEPT vs KONEPT vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.